100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Exam 4: NURS 620/ NURS620 (New 2024/ 2025 Update) Adult/Gerontology Health Care I Guide with Qs & As| 100% Correct| Grade A (Verified Answers) - Maryville $10.99   Add to cart

Exam (elaborations)

Exam 4: NURS 620/ NURS620 (New 2024/ 2025 Update) Adult/Gerontology Health Care I Guide with Qs & As| 100% Correct| Grade A (Verified Answers) - Maryville

 1 view  0 purchase
  • Course
  • NURS 620/ NURS620
  • Institution
  • NURS 620/ NURS620

Exam 4: NURS 620/ NURS620 (New 2024/ 2025 Update) Adult/Gerontology Health Care I Guide with Qs & As| 100% Correct| Grade A (Verified Answers) - Maryville

Preview 4 out of 41  pages

  • October 20, 2024
  • 41
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • exam 4
  • NURS 620/ NURS620
  • NURS 620/ NURS620
avatar-seller
ace_it
ExamI4:INURSI620/INURS620I(New
Update)IAdult/GerontologyIHealthI
CareIIIGuideIwithIQsI&IAs|I100%ICorrect|
IGradeIAI(VerifiedIAnswers)-IMaryville
I
QUESTION
GenitalIherpesIstats


Answer:
•Chronic,Ilife-longIviralIinfection
•AtIleastI50ImillionIpeopleIinItheIU.S.IhaveIgenitalIherpes
•TwoItypesIhaveIbeenIidentifiedI-IHSV-1IandIHSV-2
-TheImajorityIofIcasesIofIrecurrentIgenitalIherpesIareIcausedIbyIHSV-2

studiesIshowIthatIspreadingIisIdoneIbyIskinItoIskinIcontact,IdoesntImatterIifIlesionsIareIallIhea
led.




QUESTION
GenitalIherpesIS/S


Answer:
•SymptomsI-
-PrimaryIherpesI-Ifever,Ichills,Imalaise,Idysuria,Imultiple,IpainfulIvesicularIlesions
-RecurrentIherpesI-
IrecurrentIoutbreakIofIlesions,IlessIpainfulI,IbutIprecededIbyIprodromalIsymptoms

•PhysicalIexaminationI-IcharacteristicIlesionsIareIvisibleI-
IvesicularIandIexquisitelyItenderItoItouch

•DiagnosticItestingI-IviralIculture,IPCR

,QUESTION
GenitalIherpesItreatment


Answer:
•Treatment
-SuppressiveItherapyIforIrecurrentIgenitalIherpes
•AcyclovirI400ImgIBIDIOR
•ValcyclovirI500ImgIdaily
-EpisodicItherapyIforIrecurrentIgenitalIherpes
•AcyclovirI400ImgITIDIxI5IdaysIOR
•ValcyclovirI500ImgIBIDIxI3Idays




QUESTION
Sphyillis


Answer:
•CausedIbyITreponemaIpallidum
•TheIriskIofIdevelopingIsyphilisIafterIcontactIwithIanIinfectedIindividualIisI50%
•InI2006,I64%IofItheIreportedIprimaryIandIsecondaryIsyphilisIcasesIwereIamongImenIwhoIha
veIsexIwithImen
•InfectionImanifestsIinIdistinctIstages




QUESTION
StagesIofIsyphilis


Answer:
•PrimaryIsyphilis
-ClassicIskinIlesionI-IcalledIchancre-Idevelops
-Painless,Irounded,Iulcer

•SecondaryIsyphilis
-MaculopapularIrashIdevelopsI-IincludingIpalmsIandIsolesIofIfeet

•TertiaryIsyphilis

,-
NeurologicIandIcardiacImanifestationsIincludingImurmurs,ICHF,Imeningitis,IcranialInerveIpals
ies,IcognitiveIdysfunction,ImotorIandIsensoryIdeficits




QUESTION
DiagnosticItestingIandItreatmentIforIsyphilis


Answer:
•DiagnosticItestingI-IRPRIantibodyIlevel
•TreatmentIofIprimaryIandIsecondaryIsyphilis
-PenicillinIGI-I2.4ImillionIunitsIIM
-DoxycyclineI100ImgIBIDIxI14IdaysI(ifIpenIallergy)
•TreatmentIofItertiaryIsyphilis
-PenicillinIGI-
I7.2ImillionIunitsItotalIadministeredIasI3IdosesIofI2.4ImillionIunitsIIMIatI1IweekIintervals




QUESTION
ScreeningIrecommendationIforIcervicalIscreenings.


Answer:
ACS,IACOG,IUSPSTFIguidelines
•StartIatIageI21Iyears,IregardlessIofIsexualIactivity
•WomenIageI21I-I29IshouldIbeIscreenedIeveryI3Iyears
•WomenIoverI30IwithI2IconsecutiveInegativeIPapsIcanIbeIscreenedIeveryI5Iyears
•PapIyearlyIifIriskIfactors
•StopIcervicalIcancerIscreeningIatI65IwhoIhaveI3IorImoreInegativeIPapsIinIaIrowIandInoIabno
rmalIinItheIpastI10Iyears.
•StopIPapsIinIwomenIregardlessIofIageIwhoIhaveIaItotalIhysterectomyI(uterusIandIcervix)IforI
non-cancerIreasonsIasIlongIasItheyIhaveInoIhistoryIofIhighIgradeICIN




QUESTION
ExceptionsItoIcervicalIscreeningIguidelines

, Answer:
•AbnormalIpapIsmear
-NeedIannualIpapItillI2Inormal,IthenIfollowIguidelines
•Hx.IOfIcervicalIorIuterineIcancer
-ContinueIscreeningIpastI65ItillI20IyearsIcancerIfree
•Hysterectomy
-NoIPapIsmearIunlessIcancer




QUESTION
RiskIfactorsIforIcervicalIcancer


Answer:
•RiskIfactorsIforIcervicalIcancer
-SexualIintercourseIatIearlyIage
-MultipleIpartnersIoverIlifetime
-Age:I40-50
-LowerIsocioeconomicIstatus
-CigaretteIsmoking
-ImmuneIdeficiencyIdiseaseI(HIV)
•InfectionIwithIHPVIcauseIofI(IOVER)>I95%Icancers




QUESTION
HPVItesting


Answer:
•HPVIDNAITest:IidentifiesI13IhighIriskItypes
•UsedIinIconjunctionIwithIPap
•NotIaIsubstituteIforIPap
•DirectsIfollow-upIplanIifIcertainIpapIabnormalities,Ii.e.IASCUS




QUESTION
classificationsIforIissuesIwithIpaps

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller ace_it. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72042 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.99
  • (0)
  Add to cart